GI Dynamics

IPO

RESET® Type 2 Diabetes Treatment - Morphic Medical

Boston, United States · Founded 2003 · $10.0M raised

Headquarters
Boston
Founded
2003
Business Model
B2B
Total Funding
$10.0M
Last Round
$10.0M Series AAug 2019
Rounds
1

About

Since its founding in 2003, Morphic Medical (formerly GI Dynamics) has developed RESET, the world's first endoscopically delivered device therapy for type 2 diabetes and obesity, designed to bridge the treatment gap between pharmaceuticals and surgery. The Boston-based company is approved for sale in the EU and UK and is currently enrolling U.S. patients in its STEP-1 clinical trial.

Summary

GI Dynamics is a Healthcare company based in Boston, United States, founded in 2003. It has raised $10.0M in total across 1 round, most recently a $10.0M Series A round in Aug 2019. Investors include Crystal Amber.

Tech & App Stack

5 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

IPOSep 2019
$80.0M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies